SMMT
Summit Therapeutics Inc
Price:  
24.61 
USD
Volume:  
3,444,722.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SMMT WACC - Weighted Average Cost of Capital

The WACC of Summit Therapeutics Inc (SMMT) is 8.5%.

The Cost of Equity of Summit Therapeutics Inc (SMMT) is 13.45%.
The Cost of Debt of Summit Therapeutics Inc (SMMT) is 5.00%.

Range Selected
Cost of equity 10.40% - 16.50% 13.45%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.0% - 10.1% 8.5%
WACC

SMMT WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.42 2.07
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.40% 16.50%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.0% 10.1%
Selected WACC 8.5%